Kevin Tang

CIK: 0001178579

Transaction Breakdown

Open Market Buys (P)62 (95.4%)

High conviction signal

Open Market Sales (S)1 (1.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (3.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

NNDM

Nano Dimension Ltd.

10% Owner

BOLD

Boundless Bio, Inc.

10% Owner

FULC

Fulcrum Therapeutics, Inc.

10% Owner

AUPH

Aurinia Pharmaceuticals Inc.

DirectorOfficer10% Owner

OMIC

Singular Genomics Systems, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (65 total)

BOLD
Boundless Bio, Inc.
Oct 27, 2026
Purchase(P)
Indirect
10.7K shares at avg. $2.40$26K
BOLD
Boundless Bio, Inc.
Oct 26, 2026
Purchase(P)
Indirect
9.6K shares at avg. $2.38$23K
BOLD
Boundless Bio, Inc.
Oct 23, 2026
Purchase(P)
Indirect
6.2K shares at avg. $2.38$15K
BOLD
Boundless Bio, Inc.
Oct 22, 2026
Purchase(P)
Indirect
5.8K shares at avg. $2.40$14K
BOLD
Boundless Bio, Inc.
Oct 20, 2026
Purchase(P)
Indirect
220 shares at avg. $2.37$521.4
BOLD
Boundless Bio, Inc.
Oct 19, 2026
Purchase(P)
Indirect
18.3K shares at avg. $2.33$43K
BOLD
Boundless Bio, Inc.
Oct 19, 2026
Purchase(P)
Indirect
12.8K shares at avg. $2.34$30K
BOLD
Boundless Bio, Inc.
Oct 16, 2026
Purchase(P)
Indirect
118.2K shares at avg. $2.34$277K
BOLD
Boundless Bio, Inc.
Aug 26, 2026
Sale(S)
Indirect
18.3K shares at avg. $2.97$54K
BOLD
Boundless Bio, Inc.
Jul 21, 2026
Purchase(P)
Indirect
3K shares at avg. $2.44$7K
BOLD
Boundless Bio, Inc.
Jul 20, 2026
Purchase(P)
Indirect
1.6K shares at avg. $2.44$4K
BOLD
Boundless Bio, Inc.
Jul 17, 2026
Purchase(P)
Indirect
265 shares at avg. $2.44$646.6
FULC
Fulcrum Therapeutics, Inc.
Jul 17, 2026
Purchase(P)
Indirect
50.9K shares at avg. $3.52$179K
FULC
Fulcrum Therapeutics, Inc.
Jul 16, 2026
Purchase(P)
Indirect
116.7K shares at avg. $3.56$415K
BOLD
Boundless Bio, Inc.
Jul 16, 2026
Purchase(P)
Indirect
18.5K shares at avg. $2.44$45K
BOLD
Boundless Bio, Inc.
Jul 15, 2026
Purchase(P)
Indirect
1.6K shares at avg. $2.44$4K
FULC
Fulcrum Therapeutics, Inc.
Jul 15, 2026
Purchase(P)
Indirect
107.4K shares at avg. $3.56$382K
BOLD
Boundless Bio, Inc.
Jul 14, 2026
Purchase(P)
Indirect
43.9K shares at avg. $2.43$107K
FULC
Fulcrum Therapeutics, Inc.
Jul 14, 2026
Purchase(P)
Indirect
76K shares at avg. $3.58$272K
FULC
Fulcrum Therapeutics, Inc.
Jul 14, 2026
Purchase(P)
Indirect
53.7K shares at avg. $3.56$191K
FULC
Fulcrum Therapeutics, Inc.
Jul 13, 2026
Purchase(P)
Indirect
13K shares at avg. $3.54$46K
BOLD
Boundless Bio, Inc.
Jul 13, 2026
Purchase(P)
Indirect
48.2K shares at avg. $2.42$117K
BOLD
Boundless Bio, Inc.
Jul 10, 2026
Purchase(P)
Indirect
43.4K shares at avg. $2.43$105K
BOLD
Boundless Bio, Inc.
Jul 9, 2026
Purchase(P)
Indirect
7 shares at avg. $2.48$17.36
BOLD
Boundless Bio, Inc.
Jul 8, 2026
Purchase(P)
Indirect
14.3K shares at avg. $2.46$35K

		Type	Shares	Price		Ownership
Oct 27, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	10,707	$2.40	$25,697	Indirect
Oct 26, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	9,606	$2.38	$22,862	Indirect
Oct 23, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	6,234	$2.38	$14,837	Indirect
Oct 22, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	5,800	$2.40	$13,920	Indirect
Oct 20, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	220	$2.37	$521	Indirect
Oct 19, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	18,279	$2.33	$42,590	Indirect
Oct 19, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	12,790	$2.34	$29,929	Indirect
Oct 16, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	118,185	$2.34	$276,553	Indirect
Aug 26, 2026	BOLD Boundless Bio, Inc.	Sale(S)	18,300	$2.97	$54,351	Indirect
Jul 21, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	2,975	$2.44	$7,259	Indirect
Jul 20, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	1,623	$2.44	$3,960	Indirect
Jul 17, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	265	$2.44	$647	Indirect
Jul 17, 2026	FULC Fulcrum Therapeutics, Inc.	Purchase(P)	50,945	$3.52	$179,326	Indirect
Jul 16, 2026	FULC Fulcrum Therapeutics, Inc.	Purchase(P)	116,671	$3.56	$415,349	Indirect
Jul 16, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	18,491	$2.44	$45,118	Indirect
Jul 15, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	1,600	$2.44	$3,904	Indirect
Jul 15, 2026	FULC Fulcrum Therapeutics, Inc.	Purchase(P)	107,377	$3.56	$382,262	Indirect
Jul 14, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	43,878	$2.43	$106,624	Indirect
Jul 14, 2026	FULC Fulcrum Therapeutics, Inc.	Purchase(P)	75,952	$3.58	$271,908	Indirect
Jul 14, 2026	FULC Fulcrum Therapeutics, Inc.	Purchase(P)	53,651	$3.56	$190,998	Indirect
Jul 13, 2026	FULC Fulcrum Therapeutics, Inc.	Purchase(P)	12,966	$3.54	$45,900	Indirect
Jul 13, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	48,211	$2.42	$116,671	Indirect
Jul 10, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	43,367	$2.43	$105,382	Indirect
Jul 9, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	7	$2.48	$17	Indirect
Jul 8, 2026	BOLD Boundless Bio, Inc.	Purchase(P)	14,338	$2.46	$35,271	Indirect

1-25 of 65 transactions

About TANG KEVIN

TANG KEVIN (SEC CIK 0001178579) files insider reports with the SEC as 10% Owner of Nano Dimension Ltd. (NNDM), 10% Owner of Boundless Bio, Inc. (BOLD) and 10% Owner of Fulcrum Therapeutics, Inc. (FULC). Signal8 also holds filings tied to 2 other companies.

Signal8 holds 24 ownership filings by TANG KEVIN (5 Form 3, 19 Form 4), filed between Sep 18, 2024 and Oct 29, 2026. Those filings report 65 transactions, from Sep 16, 2024 to Oct 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on TANG KEVIN's filings is in SAN DIEGO, CA.

Recent filings by TANG KEVIN

Oct 27, 2026: Open-market purchase of BOLD shares (Form 4, code P).
Oct 26, 2026: Open-market purchase of BOLD shares (Form 4, code P).
Oct 23, 2026: Open-market purchase of BOLD shares (Form 4, code P).
Oct 22, 2026: Open-market purchase of BOLD shares (Form 4, code P).
Oct 20, 2026: Open-market purchase of BOLD shares (Form 4, code P).

Other insiders filing for Nano Dimension Ltd. (NNDM)

Murchinson Ltd., 10% Owner
Brenton John, Chief Financial Officer
KIDRON NADAV, Director
Rozenbaum Moshe H, Interim CEO
Tarlow Eliezer Eli, Director
Fruchthandler Pinchos, Director

How to read Form 4 transaction codes